SK Biopharmaceuticals Co Ltd

326030

Company Profile

  • Business description

    SK Biopharmaceuticals Co Ltd is a pharmaceutical company engaged in research and development of new drugs for treatment of central nervous system (CNS) disorders. The company is also researching for the development of drugs to treat brain tumors, including metastatic tumors. It has a Bio Science Research Institute in Pangyo Techno Valley in Gyeonggi Province. Its drugs in pipeline include Cenobamate, Solriamfetol, Carisbamate, Relenopride, SKL13865, SKL20540, SKL-PSY, and SKL24741.

  • Contact

    221, Pangyoyeok-ro
    Bundang-gu
    Gyeonggi-do
    Seongnam-si13494
    KOR

    T: +82 3180930114

    https://www.skbp.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    265

Stocks News & Analysis

stocks

A collection of our best stock opportunities

Our latest articles about where we see opportunities in the market.
stocks

Morningstar analyst reacts to Macquarie Group’s earnings

Banking Analyst Nathan Zaia’s analysis of MQG’s results.
stocks

Undervalued ASX share showing progress in global efforts

More clarity on the path forward in the UK.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,017.5050.800.57%
CAC 407,857.3656.480.72%
DAX 4024,217.37247.011.03%
Dow JONES (US)44,632.99204.57-0.46%
FTSE 1009,136.3254.880.60%
HKSE25,416.42108.03-0.42%
NASDAQ21,098.2980.29-0.38%
Nikkei 22540,657.4817.07-0.04%
NZX 50 Index12,963.5027.090.21%
S&P 5006,370.8618.91-0.30%
S&P/ASX 2008,758.6054.000.62%
SSE Composite Index3,626.1216.410.45%

Market Movers